FDA and EMA Biosimilar Approvals

Lignende værker

• The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA
  af: Gherghescu, Ioana, et al.
  Udgivet: (2020)
• Novelty of Active Ingredients in High-Cost Brand-Name Drugs
  af: Jung, Emily H., et al.
  Udgivet: (2020)
• Association between FDA and EMA expedited approval programs and therapeutic value of new medicines: retrospective cohort study
  af: Hwang, Thomas J, et al.
  Udgivet: (2020)
• Frequency of First Generic Drug Approvals With “Skinny Labels” in the United States
  af: Walsh, Bryan S., et al.
  Udgivet: (2021)
• Zarxio (Filgrastim-sndz): The First Biosimilar Approved by the FDA
  af: Awad, Mina, et al.
  Udgivet: (2017)